GCP
TARO

GSA Capital Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

GSA Capital Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,200
Closed -$315K – 1820
2018
Q3 		$315K Buy
+3,200
New +$346K 0.02% 1299

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

GSA Capital Partners's TARO Position: Q4 2018 in Review

GSA Capital Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 3,200 shares — an estimated $315K sold.

GSA Capital Partners first reported a position in TARO in Q3 2018 and held it in 1 quarter. The position peaked at $315K in Q3 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • GSA Capital Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • GSA Capital Partners sold 3,200 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $315K.
  • GSA Capital Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2018 and held it in 1 quarter.
  • GSA Capital Partners's Taro Pharmaceutical Industries Ltd. position peaked at $315K in Q3 2018.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on GSA Capital Partners's 13F filing for Q4 2018, filed 12 Feb 2019.